Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.30 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.30 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.30 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7515390 | 0.88 | — | — | |
| SCHEMBL25229288 | 0.82 | ALDH1A1 (0.34) | OPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL338634 | 0.80 | HSD11B1 (0.37) | — | |
| SCHEMBL5545046 | 0.78 | CETP (0.39) | — | |
| SCHEMBL25275034 | 0.77 | OPRM1 (0.36) | OPRM1OPRD1OPRK1OPRL1LTB4R | |
| SCHEMBL6704563 | 0.76 | — | — | |
| SCHEMBL13814778 | 0.75 | CETP (0.37) | — | |
| SCHEMBL5614237 | 0.75 | — | — | |
| SCHEMBL338300 | 0.75 | TSHR (0.48) | LTB4R | |
| SCHEMBL28408824 | 0.74 | OPRM1 (0.42) | OPRM1OPRD1OPRK1OPRL1LTB4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8097728-B2 | Iminosugar compounds with antiflavirus activity | PHILADELPHIA HEALTH & EDUCATION CORPORATION (US) | 2012-01-17 | — | — | US | disclosed |
| US-20090042268-A1 | IMINOSUGAR COMPOUNDS WITH ANTIFLAVIRUS ACTIVITY | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2009-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042268-A1 | IMINOSUGAR COMPOUNDS WITH ANTIFLAVIRUS ACTIVITY | INSRR, RNASEL, AGL | OPRM1 1378/4885OPRD1 1094/4885OPRK1 1886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.